Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hyperfine, Inc. - Class A Common Stock (NQ: HYPR )

2.000 -0.010 (-0.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,545
Open 2.030
Bid (Size) 1.960 (2)
Ask (Size) 2.080 (1)
Prev. Close 2.010
Today's Range 1.980 - 2.040
52wk Range 0.6800 - 3.280
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase
From Hyperfine, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
+140.82%
+140.82%
1 Month
-0.99%
-0.99%
3 Month
-10.71%
-10.71%
6 Month
+60.64%
+60.64%
1 Year
+76.99%
+76.99%

More News

Read More
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System
From Hyperfine, Inc.
Via Business Wire
Recap: Hyperfine Q1 Earnings
Via Benzinga
Hyperfine's Earnings: A Preview
Via Benzinga
Earnings Scheduled For August 14, 2023
Via Benzinga
Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer
From Hyperfine, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Reports First Quarter 2023 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Earnings Scheduled For March 21, 2023
Via Benzinga
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations
From Hyperfine, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.